erythrosine has been researched along with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumann, J; Gassmann, M; Huang, SF; Ogunshola, OO; Tsao, CC | 1 |
1 other study(ies) available for erythrosine and 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide
Article | Year |
---|---|
Furin inhibition prevents hypoxic and TGFβ-mediated blood-brain barrier disruption.
Topics: Amino Acid Chloromethyl Ketones; Animals; Benzamides; Blood-Brain Barrier; Capillary Permeability; Cell Membrane Permeability; Cell Movement; Cells, Cultured; Dioxoles; Endothelial Cells; Enzyme Inhibitors; Fluoresceins; Furin; Hypoxia; Male; Rats; Rats, Wistar; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta | 2019 |